Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
0.05≤C<100 <0.01
General Information
Version
1.3/IE (eng
Revision date
2024-10-07
Product name
GRIFFEN
1.2.1 Relevant identified uses
Herbicide
Emergency telephone
+353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
Sharda Cropchem Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
regn@shardaintl.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H317, H373, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07 GHS08 GHS09
Signal word
Warning
Contains
flufenacet (ISO); N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2- yloxy)acetamide; 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one
Hazard statements
H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H373 - May cause damage to organs (nervous system) through prolonged or repeated exposure. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P261 – Avoid breathing spray. P270 – Do not eat, drink or smoke when using this product. P280 - Wear eye protection, face protection, protective clothing, protective gloves. P301+P312 - IF SWALLOWED: Call a POISON CENTER or doctor if you feel unwell. P302+P352 - IF ON SKIN: Wash with plenty of water. P391 – Collect spillage. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation..
Supplemental label elements
EUH208 – Contains flufenacet. May produce an allergic reaction. EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (oral), Category 4 H302 Skin sensitisation, Category 1 H317 Specific target organ toxicity – Repeated exposure, Category 2 H373 Hazardous to the aquatic environment – Acute Hazard, Category 1 H400 Hazardous to the aquatic environment – Chronic Hazard, Category 1 H410 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available